BSD Medical Corporation (NASDAQ:BSDM) (the "Company" or "BSD") announced today the purchase, installation and acceptance of a BSD-500 Hyperthermia System (BSD-500) by Fort Belvoir Community Hospital (Fort Belvoir). The BSD-500 was purchased in April 2011 by Fort Belvoir. The new Fort Belvoir Community Hospital opened in 2011 and is part of an integrated health care network that provides world-class medical service to the nation's wounded, active duty service members, retirees and family members. Fort Belvoir provides state-of-the art health care to beneficiaries throughout the National Capital Region. The addition of hyperthermia to the services at Fort Belvoir provides patients an additional innovative cancer treatment option and another weapon in the battle with cancer.
The BSD-500 Hyperthermia System is used to deliver therapeutic heating (hyperthermia) using either non-invasive (external) hyperthermia, which is delivered using antennas placed over the tumor, or interstitial hyperthermia, which is delivered using antennas that are inserted into the tumor, or a combination of both. The BSD-500 has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA), which is the standard FDA approval required to market Class III medical devices in the United States, for the use of hyperthermia alone or in conjunction with radiation therapy for the treatment of certain tumors.
Research shows disparity in pediatric hospital access between rural and urban areas